Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.11
↑ 98% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
-4.57
Historical baseline
PeriodValueYoY Change
2025-0.11+60.7%
2024-0.28+86.2%
2023-2.03+53.1%
2022-4.33+60.7%
2021-11.03-82.3%
2020-6.05-50.5%
2019-4.02+46.7%
2018-7.54-8.0%
2017-6.98-109.6%
2016-3.33-